financetom
Business
financetom
/
Business
/
Starbucks Fiscal Q3 Non-GAAP EPS, Revenue Decrease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Starbucks Fiscal Q3 Non-GAAP EPS, Revenue Decrease
Jul 30, 2024 1:39 PM

04:18 PM EDT, 07/30/2024 (MT Newswires) -- Starbucks ( SBUX ) reported fiscal Q3 non-GAAP earnings Tuesday of $0.93 per share, down from $1 a year earlier.

Analysts polled by Capital IQ expected $0.93.

Net revenue for the quarter ended June 30 was $9.11 billion, down from $9.17 billion a year earlier.

Analysts surveyed by Capital IQ expected $9.25 billion.

Price: 77.29, Change: +1.35, Percent Change: +1.78

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive-Trump's transition team aims to kill Biden EV tax credit
Exclusive-Trump's transition team aims to kill Biden EV tax credit
Nov 15, 2024
(Reuters) - President-elect Donald Trump's transition team is planning to kill the $7,500 consumer tax credit for electric-vehicle purchases as part of broader tax-reform legislation, two sources with direct knowledge of the matter told Reuters. Ending the tax credit could have grave implications for an already stalling U.S. EV transition. And yet representatives of Tesla - by far the nation's...
FirstEnergy Gets $50 Million Smart Grid Grant
FirstEnergy Gets $50 Million Smart Grid Grant
Nov 15, 2024
12:10 PM EST, 11/14/2024 (MT Newswires) -- FirstEnergy ( FE ) said Thursday it has secured $50 million in federal funding for projects that will make electric service more reliable for over 53,000 customers in West Virginia and Maryland. The funding from the US Department of Energy's Grid Deployment Officer will be applied toward system upgrades totaling almost $127 million,...
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
EU regulator backs Eisai-Biogen Alzheimer's drug after initial rejection
Nov 15, 2024
Nov 14 (Reuters) - The European Union's drugs regulator on Thursday recommended approval for Eisai ( ESALF ) and Biogen's Leqembi in some patients with early Alzheimer's disease, nearly four months after it first rejected the treatment. The backing could make it the first treatment in the EU for the mind-wasting condition if the recommendation is accepted by the European...
No joke: the Onion buys Alex Jones' Infowars out of bankruptcy
No joke: the Onion buys Alex Jones' Infowars out of bankruptcy
Nov 15, 2024
NEW YORK (Reuters) -Like a headline befitting the Onion, the parody news website is buying conspiracy theorist Alex Jones' Infowars in a bankruptcy auction.  The Onion said in a statement on Thursday it aims to replace Infowars' relentless barrage of disinformation with the Onion's noticeably less hateful disinformation.  Jones filed for bankruptcy protection in 2022 after courts ordered him to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved